Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2023 0 14,848        
Balance at Dec. 31, 2023 $ 0 $ 15 $ 251,580 $ 156 $ (239,145) $ 12,606
Net loss $ 0 $ 0 0 0 (3,429) (3,429)
Equity financing, net (in shares) 0 2,997        
Equity financing, net $ 0 $ 3 3,967 0 0 3,970
Matching contribution to 401(k) plan (in shares) 0 163        
Matching contribution to 401(k) plan $ 0 $ 0 237 0 0 237
Equity incentive plan (in shares) 0 88        
Equity incentive plan $ 0 $ 0 0 0 0 0
Stock-based compensation expense 0 0 376 0 0 376
Foreign currency translation adjustments $ 0 $ 0 0 291 0 291
Balance (in shares) at Mar. 31, 2024 0 18,096        
Balance at Mar. 31, 2024 $ 0 $ 18 256,160 447 (242,574) 14,051
Balance (in shares) at Dec. 31, 2024 0 22,203        
Balance at Dec. 31, 2024 $ 0 $ 22 262,203 957 (250,475) 12,707
Net loss $ 0 $ 0 0 0 (2,891) (2,891)
Equity financing, net (in shares) 0 2,816        
Equity financing, net $ 0 $ 3 2,954 0 0 2,957
Deemed dividend [1] $ 0 $ 0 226 0 (226) 0
Exercise of Pre-Funded Warrants (in shares) 0 2,565        
Exercise of Pre-Funded Warrants $ 0 $ 2 0 0 0 2
Matching contribution to 401(k) plan (in shares) 0 556        
Matching contribution to 401(k) plan $ 0 $ 1 235 0 0 236
Equity incentive plan (in shares) 0 57        
Equity incentive plan $ 0 $ 0 0 0 0 0
Stock-based compensation expense 0 0 214 0 0 214
Foreign currency translation adjustments $ 0 $ 0 0 (533) 0 (533)
Balance (in shares) at Mar. 31, 2025 0 28,197        
Balance at Mar. 31, 2025 $ 0 $ 28 $ 265,832 $ 424 $ (253,592) $ 12,692
[1] Refer to Note 11. Capitalization and Equity Structure – Warrants for additional information regarding the Stockholder Dividend and the valuation of warrants.